CORRECTION: Regarding additions to the agenda of the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
156
CORRECTION: Regarding additions to the agenda of the ordinary general meeting of shareholders of AB VILNIAUS BALDAI to be held on 20 December 2017

Vilnius, Lithuania, 2017-12-08 08:00 CET (GLOBE NEWSWIRE) --  

On the proposal and decision to additions of the Company's Management Board the Ordinary General Shareholders Meeting of Vilniaus baldai AB (identification code 121922783, address Savanoriu ave. 178B, Vilnius, LT-03154) is to be held on 20 December, 2017 at 10:00 a. m. in Savanoriu ave. 178B, Vilnius.  

Registration of the shareholders will start at 9:30 a. m. Only the persons who are the shareholders of the Company at the end of the accounting day of the Ordinary General Shareholders Meeting (13 December, 2017) are entitled to participate and to vote at the General Shareholders meeting. Shareholders‘ rights accounting day – 08 January, 2018.  

Agenda of the ordinary general meeting of shareholders (including its supplemented issues):  

1. Consolidated annual report.  2. Company’s Auditor‘s report. 3. Approval of the Consolidated and Company's financial statements for the year 2017 ended 31 August  2017. 4. Distribution of Company's profit. 5. Approval of the new wording of the provisions of the Audit Committee. 6. Election of the audit committee members. 7. Determination of remuneration for the audit committee members.    

The Management Board of Vilniaus baldai AB approved the Company‘s draft resolutions of the Annual General Shareholders meeting that will take place on the 20 th of December 2017:  

1. Consolidated annual report.  

Shareholders of the public joint-stock company Vilniaus baldai AB are presented with the consolidated annual report of Vilniaus baldai for 2017 (There is no voting on this issue of agenda).  

2. Independent auditor's report.

Shareholders of the public joint-stock company Vilniaus baldai AB are presented with the independent auditor's report on the financial statements of Vilniaus baldai for 2017 (There is no voting on this issue of agenda).  

3. Approval of the Consolidated and Company's financial statements for the year 2017 ended 31 August 2017.

To approve Consolidated and Company's financial statements for the year 2017 ended 31 August 2017.    

4. Approval of the Company‘s profit distribution for the year 2017 ended 31 August 2017:

To approve Company‘s profit distribution:  

Undistributed retained earnings, brought forward 5 233 266 EUR
Net result for the current year 4 422 779 EUR
Profit (loss) not recognized in the income statement of the reporting financial year   (21 479) EUR
Distributable result 9 634 566 EUR
Transfers to the obligatory reserves                       -
Transfers to other reserves                       -
To be paid as dividends* 1 049 292 EUR
To be paid as annual payments (bonus) to the Board members                       -
Undistributed retained earnings, carried forward           8 585 274 EUR

* 0.27 EUR of dividends per one ordinary share.  

5. Approval of the new wording of the provisions of the Audit Committee.

To approve the regulations of the Audit Committee of Vilniaus baldai AB (enclosed).  

6. Election of the audit committee members.  

Approve composition of the Audit Committee of 3 (three) members elected for a term of 4 (four) years: independent members Tomas Bubinas and Danute Kadanaite, Audit Committee members Vaidas Savukynas. To elect Tomas Bubinas, Chairman of the Audit Committee.          

7. Regarding approval of the remuneration for the Audit Committee members.  

To set a rate not higher than EUR 100 per hour for a work in the Audit Committee of Vilniaus baldai AB. To delegate to the Board of the Company to determine the remuneration payment procedure for the Audit Committee members.    

The documents related to the agenda, draft resolutions on every item of agenda, documents what have to be submitted to the General Shareholders Meeting and other information related to realization of shareholders rights are available at the office of Vilniaus baldai (Savanoriu ave 178 B, Vilnius) during working hours.  

The Company provided the information, which according to legal acts must be provided when notifying of the convocation of the meeting, on 28 November 2017 by publishing the notification on material event.  

Documents related to the agenda updates are attached including: draft of the new version of the Audit Committee provisions, list of proposed candidates for the members of the Audit Committee, proposal for setting Audit Committee members remuneration, respectively updated general voting bulletin.    

         Additional information:          Head of Finance          Jonas Krutinis          Phone No.: +370 (5) 252 57 00

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 147

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Early Dog Guarding Signs Matter Before a Sudden Growl

Updated Category News Views 92

A bowl, a chewed-up toy, or a patch of couch can turn tense in a heartbeat. That is why the useful part of Brian Manning's guidance is not some fantasy of making every dog endlessly tolerant; it is learning to notice discomfort while there is still room to back off safely. For anybody watching the pet-care and behavior-training field, this is the kind of plainspoken...

Continue Reading
Humanoid Robots Need Results Before 2035 Hype Peaks

Updated Category News Views 245

A robot climbing stairs is neat; a robot finishing Tuesday’s shift is the investment case. The latest humanoid robotics forecast puts the global market at $3.07 billion in 2026, up from $2.26 billion in 2025, and projects $47.49 billion by 2035. That is a 35.59% compound annual growth rate, the kind of number that makes investors sit up straight. It also demands a...

Continue Reading
Health In Tech Brings a Tech Veteran Onto Its Board

Updated Category News Views 115

Board appointments rarely make the cash register ring, but they can tell you where management thinks the next bruises are coming from. Health In Tech has added Tim Cortes as an independent director, put him in charge of the Compensation Committee, and placed him on both the Audit and Nominating and Corporate Governance Committees. For an AI-enabled insurance technology...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 168

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Clarivate's 2026 Research List Carries a Trust Test

Updated Category News Views 254

Seven thousand ninety awards can look like a victory lap until you remember how easily raw citation counts can be gamed. Clarivate’s 2026 Highly Cited Researchers list is more interesting for its insistence on screening than for the familiar names at the top. In a research world where publication volume, self-citation and paper mills have made plenty of people...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 158

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
Peñoles Locks In Solar Storage for Northern Mine Loads

Updated Category News Views 54

A mine never sleeps, which is why the battery matters more than the solar-panel headline. Peñoles has signed a 20-year power-supply agreement with Atlas Renewable Energy for a Coahuila project combining 269 MWp of solar generation with battery storage. The project is slated to begin operating in the first half of 2029 and is expected to provide roughly 550 GWh a year to...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 68

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Workday’s EU Cloud Move Raises the Sovereignty Bar Again

Updated Category News Views 124

Europe’s sovereignty squeeze just got a lot more concrete for Workday. The company is taking its EU Sovereign Cloud beyond the usual data-residency talking points by planning an Ireland-based operating company, European leadership, and governance intended to keep decisions on the service and customer data inside Europe. For a platform sitting underneath payroll, HR...

Continue Reading

Top 5 Most Recently Viewed Articles

Hepsiburada's Impressive Q3 2025 Performance Review

Updated Category News Views 281

Hepsiburada Reports Significant Gains in Q3 2025 Hepsiburada, officially known as D-MARKET Electronic Services & Trading (NASDAQ: HEPS), has unveiled robust financial results for the third quarter of 2025. The Turkish e-commerce giant reported an impressive increase in gross merchandise value (GMV) and revenue, highlighting the company's operational resilience in a...

Continue Reading
Fulcrum Therapeutics Faces Challenges Amid Sickle Cell Trials

Updated Category News Views 212

Market Moves and Stock Reactions So, let’s get straight to the meat of it. Fulcrum Therapeutics Inc. (NASDAQ:FULC) took a nosedive recently—down about 10%—right after they dropped the latest news on their Phase 1b trial for pociredir aimed at treating sickle cell disease. Stock fell to around $9.80, and honestly, if you're still holding shares, well, it's time to...

Continue Reading
SBM Offshore's Share Repurchase Program Insights and Updates

Updated Category News Views 215

Overview of SBM Offshore’s Share Repurchase Program SBM Offshore has recently conducted a significant share repurchase program amounting to EUR141 million (approximately US$150 million). This initiative began on April 24, 2025, and aims to reduce share capital while also supporting management and employee share programs. The program has been designed to both enhance...

Continue Reading
Plymouth Industrial REIT Responds to Acquisition Proposal

Updated Category News Views 212

Plymouth Industrial REIT Receives Unsolicited Acquisition Proposal Plymouth Industrial REIT, Inc. (NYSE: PLYM), a leader in the industrial real estate sector, recently attracted attention with an unsolicited and non-binding acquisition proposal. This proposal comes from Sixth Street Partners, LLC, and suggests a price of $24.10 per share for all outstanding shares of the...

Continue Reading
Middlefield Canadian Income PCC AGM Results Breakdown

Updated Category News Views 230

Overview of the AGM Results for Middlefield Canadian Income PCC Middlefield Canadian Income PCC (the "Company") and Middlefield Canadian Income - GBP PC (the "Cell") have recently concluded their annual general meeting, a significant event that spotlighted the Company's journey and future direction. Conducted with transparency and diligence, this meeting has underscored...

Continue Reading